Bibliometric Analysis of Neoadjuvant Therapy for Gastric Cancer Research

Zhongke Wang's bibliometric analysis includes 2,666 publications on neoadjuvant therapy for gastric cancer. The study visualizes research trends, top-producing countries like China, and key authors such as Huang, Changming. It identifies future research directions including deep learning and immunotherapy applications.

Use Cases

• Analyze publication trends and country-level contributions like China from the 2,666-document corpus.
• Map co-citation networks of authors and journals, including top-cited author Al-batran and journal Journal of Clinical Oncology.
• Identify keyword clusters and research hotspots such as diverse NAT strategies and open-label trials.
• Study the evolution of research themes over time, including emerging trends like immune checkpoint inhibitors and nivolumab.

Strengths

• Analysis is based on a substantial corpus of 2,666 scientific publications.
• Identifies specific top entities, including the leading country (China) and most cited author (Al-batran).
• Employs established bibliometric tools (Citespace and Vosviewer) for visual analysis.
• Clear open license (CC BY 4.0) facilitates reuse and sharing.

Limitations

• The dataset is very small (22.9 KB), containing only the analysis document, not the underlying publication data.
• As a static analysis document, it cannot be updated or queried for new trends after its publication date.
• The scope is limited to publications from Web of Science and PubMed, potentially excluding relevant research from other databases.

Provenance

Source

Publications collected from Web of Science (SCI-Expanded) and PubMed.

Collection Method

Bibliometric analysis using Citespace and Vosviewer software.

Freshness

Last updated March 25, 2026, indicating a forward-looking analysis.

Geography

Global, with specific mention of top-producing country China.